Covered recipient · General Payments record
JOSHUA SETH MERVIS
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2020–2024
$13,738.98
- Reported across 120 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,758.78 | 49 |
| Consulting Fee | $750.00 | 1 |
| Education | $99.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $750.00 | 1 |
| UCB, Inc. | $458.91 | 18 |
| ABBVIE INC. | $370.94 | 10 |
| ORGANOGENESIS INC. | $161.39 | 1 |
| E.R. Squibb & Sons, L.L.C. | $156.54 | 7 |
| AVITA MEDICAL AMERICAS, LLC | $154.09 | 2 |
| CHIESI USA, INC. | $140.00 | 1 |
| Janssen Biotech, Inc. | $133.78 | 2 |
| MIMEDX Group, Inc. | $86.25 | 1 |
| Lilly USA, LLC | $67.55 | 2 |
| Smith & Nephew, Inc. | $55.99 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $50.82 | 2 |
| Krystal Biotech Inc | $22.51 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (51)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $33.90 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105026132 | CMS |
| ABBVIE INC. | $32.01 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105026134 | CMS |
| ABBVIE INC. | $102.24 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105026136 | CMS |
| ABBVIE INC. | $30.26 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105026138 | CMS |
| ABBVIE INC. | $22.80 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105026140 | CMS |
| ABBVIE INC. | $34.38 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105026142 | CMS |
| ABBVIE INC. | $24.04 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105026144 | CMS |
| ABBVIE INC. | $32.52 | 11/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105026146 | CMS |
| ABBVIE INC. | $33.68 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105026148 | CMS |
| ABBVIE INC. | $25.11 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105026150 | CMS |
| Avita Medical Americas, Llc | $8.68 | 08/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126205201 | CMS |
| Avita Medical Americas, Llc | $145.41 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126204727 | CMS |
| Chiesi USA, Inc. | $140.00 | 10/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151813602 | CMS |
| E.R. Squibb & Sons, L.L.C. | $30.60 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101762514 | CMS |
| E.R. Squibb & Sons, L.L.C. | $6.27 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101762525 | CMS |
| E.R. Squibb & Sons, L.L.C. | $28.36 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101762532 | CMS |
| E.R. Squibb & Sons, L.L.C. | $22.83 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101762551 | CMS |
| E.R. Squibb & Sons, L.L.C. | $7.09 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101762588 | CMS |
| E.R. Squibb & Sons, L.L.C. | $31.23 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101762599 | CMS |
| E.R. Squibb & Sons, L.L.C. | $30.16 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101762629 | CMS |
| Janssen Biotech, Inc. | $99.99 | 05/02/2024 | Education | Undisputed | 01/23/2026 | 1078690177 | CMS |
| Janssen Biotech, Inc. | $33.79 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078688573 | CMS |
| Krystal Biotech Inc | $22.51 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084810780 | CMS |
| Lilly USA, LLC | $34.70 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135109664 | CMS |
| Lilly USA, LLC | $32.85 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135087224 | CMS |
| Merck Sharp & Dohme LLC | $750.00 | 12/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141683291 | CMS |
| MIMEDX Group, Inc. | $86.25 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140264919 | CMS |
| Novartis Pharmaceuticals Corporation | $18.85 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087004084 | CMS |
| Novartis Pharmaceuticals Corporation | $31.97 | 08/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087004094 | CMS |
| Organogenesis Inc. | $161.39 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145438833 | CMS |
| Smith+Nephew, Inc. | $17.27 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149596325 | CMS |
| Smith+Nephew, Inc. | $21.78 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149596327 | CMS |
| Smith+Nephew, Inc. | $16.94 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149596323 | CMS |
| UCB, Inc. | $44.42 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143315401 | CMS |
| UCB, Inc. | $110.00 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143315406 | CMS |
| UCB, Inc. | $48.15 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143315410 | CMS |
| UCB, Inc. | $17.83 | 06/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143315415 | CMS |
| UCB, Inc. | $1.61 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143315419 | CMS |
| UCB, Inc. | $12.28 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143315424 | CMS |
| UCB, Inc. | $113.62 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143315428 | CMS |
| UCB, Inc. | $6.69 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143315432 | CMS |
| UCB, Inc. | $14.26 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143315436 | CMS |
| UCB, Inc. | $38.19 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143315440 | CMS |
| UCB, Inc. | $3.02 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143315445 | CMS |
| UCB, Inc. | $0.47 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143315449 | CMS |
| UCB, Inc. | $21.85 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143315453 | CMS |
| UCB, Inc. | $6.00 | 09/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143315458 | CMS |
| UCB, Inc. | $6.00 | 09/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143315462 | CMS |
| UCB, Inc. | $2.23 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143097701 | CMS |
| UCB, Inc. | $4.28 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143097703 | CMS |
| UCB, Inc. | $8.01 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143097705 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.